[1]
“Pituitary Macroadenoma Grading Using Magnetic Resonance Imaging: A Sipap Classification Study”, Journal of Pharmaceutical Negative Results, pp. 3503–3511, Mar. 2023, doi: 10.47750/pnr.2023.14.03.435.